Investors seeking to outperform the market often focus on hand-picking stocks. Selecting the right ones has proven to be a key factor in boosting wealth.
The closing price of Cellectar Biosciences Inc (NASDAQ: CLRB) was $0.37 for the day, up 3.07% from the previous closing price of $0.35. In other words, the price has increased by $3.07 from its previous closing price. On the day, 4.7 million shares were traded.
Ratios:
Our analysis of CLRB’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 2.47 and its Current Ratio is at 2.47. In the meantime, Its Debt-to-Equity ratio is 0.05 whereas as Long-Term Debt/Eq ratio is at 0.04.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 10 ’25 when Longcor Jarrod bought 30,000 shares for $0.28 per share. The transaction valued at 8,400 led to the insider holds 83,141 shares of the business.
Stock Price History:
Over the past 52 weeks, CLRB has reached a high of $3.42, while it has fallen to a 52-week low of $0.22. The 50-Day Moving Average of the stock is 29.78%, while the 200-Day Moving Average is calculated to be -60.91%.
Shares Statistics:
A total of 46.08M shares are outstanding, with a floating share count of 45.31M. Insiders hold about 1.67% of the company’s shares, while institutions hold 11.42% stake in the company.
